Literature DB >> 15194794

Nuclear sequestration of cellular chaperone and proteasomal machinery during herpes simplex virus type 1 infection.

April D Burch1, Sandra K Weller.   

Abstract

Herpes simplex virus type 1 (HSV-1) encodes a portal protein that forms a large oligomeric structure believed to provide the conduit for DNA entry and exit from the capsid. Chaperone proteins often facilitate the folding and multimerization of such complex structures. In this report, we show that cellular chaperone proteins, components of the 26S proteasome, and ubiquitin-conjugated proteins are sequestered in discrete foci in the nucleus of the infected cell. The immediate-early viral protein ICP0 was shown to be necessary to establish these foci at early times during infection and sufficient to redistribute chaperone molecules in transfected cells. Furthermore, we found that not only is the portal protein, UL6, localized to these sites during infection, but it is also a substrate for ubiquitin modification. Our results suggest that HSV-1 has evolved an elegant mechanism for facilitating protein quality control at specialized foci within the nucleus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194794      PMCID: PMC421678          DOI: 10.1128/JVI.78.13.7175-7185.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Sequential localization of two herpes simplex virus tegument proteins to punctate nuclear dots adjacent to ICP0 domains.

Authors:  Ian Hutchinson; Alison Whiteley; Helena Browne; Gillian Elliott
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.

Authors:  Chris Boutell; Seth Sadis; Roger D Everett
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  The pseudorabies virus VP22 homologue (UL49) is dispensable for virus growth in vitro and has no effect on virulence and neuronal spread in rodents.

Authors:  T del Rio; H C Werner; L W Enquist
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Host participation in bacteriophage lambda head assembly.

Authors:  C P Georgopoulos; R W Hendrix; S R Casjens; A D Kaiser
Journal:  J Mol Biol       Date:  1973-05-05       Impact factor: 5.469

5.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Genetic analysis of temperature-sensitive mutants of HSV-1: the combined use of complementation and physical mapping for cistron assignment.

Authors:  S K Weller; D P Aschman; W R Sacks; D M Coen; P A Schaffer
Journal:  Virology       Date:  1983-10-30       Impact factor: 3.616

7.  The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53.

Authors:  Chris Boutell; Roger D Everett
Journal:  J Biol Chem       Date:  2003-07-09       Impact factor: 5.157

8.  The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.

Authors:  Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-10       Impact factor: 11.205

9.  PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.

Authors:  Chris Boutell; Anne Orr; Roger D Everett
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4.

Authors:  N A DeLuca; A M McCarthy; P A Schaffer
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more
  62 in total

1.  Accumulation of oxidized proteins in Herpesvirus infected cells.

Authors:  Shomita S Mathew; Patrick W Bryant; April D Burch
Journal:  Free Radic Biol Med       Date:  2010-05-02       Impact factor: 7.376

2.  Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection.

Authors:  Dianna E Wilkinson; Sandra K Weller
Journal:  J Cell Sci       Date:  2006-06-06       Impact factor: 5.285

3.  Herpes simplex virus tegument protein VP22 contains an internal VP16 interaction domain and a C-terminal domain that are both required for VP22 assembly into the virus particle.

Authors:  Wali Hafezi; Emmanuelle Bernard; Rachelle Cook; Gillian Elliott
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction.

Authors:  Gregory T Melroe; Lindsey Silva; Priscilla A Schaffer; David M Knipe
Journal:  Virology       Date:  2006-11-28       Impact factor: 3.616

5.  Domain within herpes simplex virus 1 scaffold proteins required for interaction with portal protein in infected cells and incorporation of the portal vertex into capsids.

Authors:  Kui Yang; Joel D Baines
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

6.  Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step.

Authors:  Mark G Delboy; Devin G Roller; Anthony V Nicola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

7.  Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects.

Authors:  Ji Young Yoo; Brian S Hurwitz; Chelsea Bolyard; Jun-Ge Yu; Jianying Zhang; Karuppaiyah Selvendiran; Kellie S Rath; Shun He; Zachary Bailey; David Eaves; Timothy P Cripe; Deborah S Parris; Michael A Caligiuri; Jianhua Yu; Matthew Old; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2014-05-09       Impact factor: 12.531

8.  BAG3, a host cochaperone, facilitates varicella-zoster virus replication.

Authors:  Christos A Kyratsous; Saul J Silverstein
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  ICP27 phosphorylation site mutants are defective in herpes simplex virus 1 replication and gene expression.

Authors:  Santos Rojas; Kara A Corbin-Lickfett; Laurimar Escudero-Paunetto; Rozanne M Sandri-Goldin
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

10.  Nuclear pore composition and gating in herpes simplex virus-infected cells.

Authors:  Helmut Hofemeister; Peter O'Hare
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.